Loading...
Back to narrative

Update shared on11 Sep 2025

Fair value Increased 56%
AnalystConsensusTarget's Fair Value
US$7.00
73.1% undervalued intrinsic discount
11 Sep
US$1.88
Loading
1Y
-16.1%
7D
0%

The sharp upward revision in Emeren Group's price target reflects a substantial improvement in projected net profit margin and accelerated consensus revenue growth, lifting the fair value estimate from $4.50 to $7.00.


What's in the News


  • Special/Extraordinary Shareholders Meeting scheduled in Raleigh, NC.
  • No shares repurchased in the most recent buyback period; full buyback completed with 124,703,920 shares repurchased for $49.17 million under the prior program.
  • Delayed SEC filings; company unable to file next 10-Q by the required deadline.

Valuation Changes


Summary of Valuation Changes for Emeren Group

  • The Consensus Analyst Price Target has significantly risen from $4.50 to $7.00.
  • The Net Profit Margin for Emeren Group has significantly risen from 24.09% to 38.68%.
  • The Consensus Revenue Growth forecasts for Emeren Group has significantly risen from 43.0% per annum to 55.9% per annum.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.